Indications & Dose:
Adjuvant therapy of axillary node-negative breast cancer and of node positive cancer in post-menopausal women following mastectomy, axillary dissection, and breast , irradiation; treatment-of metastatic breast cancer in both women and men; most beneficial in estrogen receptorpositive tumors; reduction in incidence of breast cancer in high-risk women (defined as >35 yr with a 5 yr predicted risk of breast cancer >1.67% as calculated by the Gail Model); also used in mastalgia, gynecomastia
DOSE
Adults
Breast cancer: 20mg daily increasing to 40mg daily if necessary.
Anovulatory infertility: 20mg daily on four successive days commencing on second day of menstruation. Increase if necessary to 40mg then 80mg for subsequent courses.
Children: Not recommended.
Contraindications:
Pregnancy
Side Effects:
CNS: Depression, headache, hot flashes, (33%) lightheadedness
CV: Chest pain
EENT: Blurred vision (high doses), corneal opacity, ocular lesion, retinopathy
GI: Abnormal liver function tests, altered taste, anorexia, hepatic necrosis, nausea, vomiting
GU: Endometrial cancer, menstrual changes (irregularity, oligomenorrhea, amenorrhea), pruritus vulvae, vaginal bleeding
HEME: Deep vein thrombosis, leukopenia, thrombocytopenia
METAB: Hypercalcemia
RESP: Pulmonary embolism
SKIN: Alopecia, rash
Cautions:
Precautions:
Leukopenia, thrombocytopenia, cataracts, liver disease, hypercalcemia, undiagnosed abnormal vaginal bleeding
Interaction:
Drugs
Aminoglutethimide: Reduces tamoxifen concentrations
Warnings:
Adverse Effects:
Lactations:
Special Precautions:
Counselling:
Side Effects Or Adverse Reactions:
Patient And Carer Advice:
© Pakistan Drug Directory. All Rights Reserved.
Designed By: Pakistan Drug Directory Team